Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News

11/11/2019 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 54% of Doctors Witnessed Statistical Distortion

The problem of statistical distortion on morbidity and mortality has more than once become the subject of discussion at the highest level. In particular, in mid-October 2019, at a meeting of the presidium of the Presidential Council on Strategic Development and National Projects, Prime Minister Dmitry Medvedev promised to take harsh measures against the leaders of the regions in which statistics are distorted.

10/29/2019 Database Update: Pharmaceutical Drug Production in Russia (September 2019)

Between January and September 2019, Russia manufactured 295 bln RUB worth of pharmaceutical drugs (manufacturers’ prices, VAT included), which is monetary terms (rubles) 22% higher than that in the same period in 2018. This is also the highest dynamics since 2016. The dynamics in physical terms (units) are +4.7%, or +4.2% if calculated in minimum dosage units (MDU). While these dynamics are far from those in 2016, these can still be considered high after the constant negative dynamics during 2017-2018.

10/29/2019 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 41% of Doctors Support Legalization of Online Pharmacy

17% of doctors believe that it is time that online sale of pharmaceutical drugs in Russia became legal, since it is not only convenient for consumers, but has long been an objective reality that cannot be ignored, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social network for doctors.

10/15/2019 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 88% of Doctors Support their Colleagues in Russian Cancer Research Center

Unfortunately, the current situation in the N.N. Blokhin Russian Cancer Research Center with possible numerous resignations of doctors is far from rare.

10/8/2019 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 45% of Doctors Believe Latin Studies Are Necessary

Russian doctors are not only professionals, but also highly erudite people. The vast majority of the respondents in an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social network for doctors consider it impossible to remove Latin from curriculum or reduce the hours in medical universities. In addition to half-joking reasons, such as “to swear in the presence of strangers” or “to learn Gaudeamus”, the doctors note the importance of “professional community”, “friend / foe criteria”, the need to “soften the diagnosis for relatives”, etc.

10/1/2019 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 46% of Doctors Ready to Work in Medical Offices at Pharmacies if Decent Salaries Provided

In early September, Pharmacy Chain 36.6 announced a new project involving medical offices in pharmacies. These offices will be equipped in accordance with the therapeutic activity license, so that customers will be able to receive qualified medical care. The RNC Pharma analyst company, together with the Doktor Na Rabote (Doctor at Work) social network for doctors, conducted on online survey to find out under what conditions a doctor can consider working in those medical offices.

9/26/2019 Database Update: Pharmaceutical Drug Production in Russia (August 2019)

Between January and August 2019, Russia produced 255.8 bln RUB worth of pharmaceutical drugs (manufacturers’ prices, VAT included), which is in monetary terms (rubles) 20.2% higher than that of the same period in 2018. In physical terms, the dynamics are +4.5%, with the production volume of 2.83 bln units. If calculated in minimum dosage units (MDU), the dynamics are +3.5%, with the production volume of 47 bln MDUs.

9/24/2019 Database Update: Import of Veterinary Drugs, Feed Supplements, and APIs to Russia (July 2019)

Between January and July 2019, Russia imported 37.7 bln RUB worth of veterinary products (free circulation prices, VAT included), which is in monetary terms (rubles) 0.1% lower than that of the same period in 2018. The negative dynamics are only due to the import of feed supplements dropping by 12.4%. However, the import of feed supplements is the leader in the volume of import in monetary terms with 19.2 bln RUB. The dynamics in physical terms (units) are only negative, -2.4%.

9/23/2019 Database Update: API Import to Russia (July 2019)

Between January and July 2019, Russia imported 69.5 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms (rubles) 26.5% higher than that of the same period in 2018. As earlier, a significant price increase contributed to the high dynamics. In physical terms (tons), the dynamics are +4.5%, with the import volume of 7 thousand tons.

9/20/2019 Pharmaceutical Drug Import to Russia (July 2019)

In July 2019, Russia imported 61.5 bln RUB worth of ready-made pharmaceuticals (free circulation prices, VAT included), which is in monetary terms (rubles) +31.5% higher than that of July 2018 and the highest volume since August 2010. Higher dynamics were witnessed in June 2016. However, the dynamics in physical terms are only +7.3%, with the import volume of 183.3 bln units.